Interacting Drugs |
Mitomycin vs Antineoplastic Agents (Vinca Alkaloids) |
Security Level |
 |
Mechanism |
Antineoplastic Agents (Vinca Alkaloids): May enhance the adverse/toxic effect of MitoMYcin. Specifically, the risk of pulmonary toxicity may be increased. |
Management |
Monitor therapy |
Mitomycin vs Antineoplastic Agents (Vinca Alkaloids)
Post Review about Mitomycin vs Antineoplastic Agents (Vinca Alkaloids) Click here to cancel reply.
Other Interactions of Mitomycin
Other Interactions of Antineoplastic Agents (Vinca Alkaloids)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.